Dragana V. Lavrnic

6, Dr. Subotic Sr. Street, 11 000
Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Risk factors for generalization of ocular myasthenia gravis.

Risk factors for generalization of ocular myasthenia gravis.

Journal: Indian journal of ophthalmology
Published: March 10, 2025

Causal Variants in CHRNA1 and CHRNB1 Genes for Anti-acetylcholine Receptor Antibody Positive Myasthenia Gravis: Evidence from Bayesian Fine-Mapping and Genetic Association Study.

Causal Variants in CHRNA1 and CHRNB1 Genes for Anti-acetylcholine Receptor Antibody Positive Myasthenia Gravis: Evidence from Bayesian Fine-Mapping and Genetic Association Study.

Journal: Molecular neurobiology
Published: February 18, 2025

Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients.

Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients.

Journal: Molecular neurobiology
Published: December 06, 2023

Galactosylation of serum immunoglobulin G in myasthenia gravis with different autoantibodies.

Galactosylation of serum immunoglobulin G in myasthenia gravis with different autoantibodies.

Journal: Scandinavian journal of clinical and laboratory investigation
Published: July 10, 2023

COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.

COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.

Journal: Acta neurologica Belgica
Published: July 02, 2022

Myasthenia gravis treated in the neurology intensive care unit: a 14-year single-centre experience.

Myasthenia gravis treated in the neurology intensive care unit: a 14-year single-centre experience.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 14, 2022

Risk factors for potential drug-drug interactions in patients with myasthenia gravis.

Risk factors for potential drug-drug interactions in patients with myasthenia gravis.

Journal: Neurological research
Published: July 08, 2021

Long-term outcome in patients with myasthenia gravis: one decade longitudinal study.

Long-term outcome in patients with myasthenia gravis: one decade longitudinal study.

Journal: Journal of neurology
Published: May 23, 2021

Longitudinal study of neuropathic pain in patients with Guillain-Barré syndrome.

Longitudinal study of neuropathic pain in patients with Guillain-Barré syndrome.

Journal: Irish journal of medical science
Published: July 09, 2020

Rate of progression of Guillain-Barré syndrome is not associated with the short-term outcome of the disease.

Rate of progression of Guillain-Barré syndrome is not associated with the short-term outcome of the disease.

Journal: Irish journal of medical science
Published: May 04, 2020

Prospective analysis of gait characteristics in chronic inflammatory demyelinating polyradiculoneuropathy.

Prospective analysis of gait characteristics in chronic inflammatory demyelinating polyradiculoneuropathy.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: April 22, 2020

Disability and quality of life in Guillain-Barré syndrome - Longitudinal study.

Disability and quality of life in Guillain-Barré syndrome - Longitudinal study.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: February 24, 2020
Showing 1-12 of 61

Last Updated: 09/26/2026